NCT03403777 2019-03-05Avelumab in Refractory Testicular Germ Cell Cancer.National Cancer Institute, SlovakiaPhase 2 Completed8 enrolled
NCT00749502 2013-07-25A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)Tesaro, Inc.Phase 1 Completed113 enrolled